Technical Intelligence & Insights
Dive into our comprehensive technical reports covering the Pharma Healthcare sector. We analyze novel patents, catalytic processes, and cost-reduction strategies to streamline your commercial manufacturing.
Patent CN104045680A details novel acetyl amino acid acyl derivatives of betulin with enhanced antitumor activity, offering scalable synthesis routes for pharmaceutical supply chains.
Novel patent method ensures high purity and safety for Ceritinib intermediate manufacturing reducing costs and improving supply chain reliability significantly.
Novel Rh-catalyzed asymmetric hydrogenation for cyclic chiral nitriles. High ee, scalable process for Ramelteon manufacturing supply chain.
Novel resolution process using L-tartaric acid improves purity >99.8% and reduces costs for reliable pharma intermediate suppliers.
Novel 8-step synthesis of 5-N-formalardeemin with >30% total yield. Optimized for industrial scale-up and cost reduction in MDR reversal agent manufacturing.
Novel ionic liquid catalyzed synthesis offers high purity pharmaceutical intermediates. Reduces cost and environmental impact for scalable commercial production.
Novel synthetic route for Apixaban intermediate CN104387383A offers high yield and reduced environmental impact for reliable pharmaceutical intermediates supplier partnerships.
Patent CN101723971B details a stable, low-cost preparation method for 1-beta-methyl carbapenem bicyclic mother nucleus, achieving 46% overall yield.
Patent CN111662889B discloses a novel ketoreductase mutant enabling efficient synthesis of Darunavir intermediates with high substrate loading and reduced costs.
Patent CN1106389C details a streamlined organozinc method for DMP-266 intermediates, offering superior enantioselectivity and eliminating protection steps for cost-effective API manufacturing.
Patent CN111039867A reveals a room-temperature photochemical route for isoquinoline derivatives, offering significant cost reduction and greener supply chain solutions for pharmaceutical intermediates.
Patent CN108456227B reveals efficient photocatalytic synthesis enabling cost reduction in pharmaceutical intermediates manufacturing with high regioselectivity.
Novel synthesis route for Hoffer's chlorosugar from Vitamin C. High purity >98.8%. Cost-effective supply for pharmaceutical intermediates manufacturing and scale.
Novel radical cascade synthesis of cyclopentadienodihydroquinolines using K2S2O8 and AgNO3. Offers mild conditions and high yields for pharmaceutical intermediates.
Novel Pd-catalyzed route for alpha-methylene-gamma-butyrolactone derivatives. Mild conditions, high functional group tolerance, scalable supply chain solutions for global pharmaceutical manufacturing partners.
Patent CN101417942B reveals high-purity synthesis route. Enables cost reduction in pharma intermediate manufacturing with scalable chromatography separation.
Novel reductive amination route for influenza inhibitor intermediates. High yield, safe scale-up, and cost-effective manufacturing solution for global pharma.
Patent CN102399166B enables high-purity THPBs synthesis. Reduces cost and improves supply chain reliability for neurological drug intermediates.
Patent CN112442025A details a novel gold-catalyzed route for imidazo[1,2-a]pyridine intermediates, offering mild conditions and high atom economy for API manufacturing.
Patent CN102395582A details aqueous alkaline synthesis yielding 99.5% purity. Offers cost reduction in API manufacturing and scalable supply chain solutions.